DNA/RNA heteroduplex oligonucleotides: An unanticipated twist in the delivery of ASOs
Author:
Funder
National Cancer Institute
Publisher
Elsevier BV
Subject
Drug Discovery,Molecular Medicine
Reference12 articles.
1. Overcoming cellular barriers for RNA therapeutics;Dowdy;Nat. Biotechnol.,2017
2. Delivery of oligonucleotide-based therapeutics: challenges and opportunities;Hammond;EMBO Mol. Med.,2021
3. Challenges and opportunities for nucleic acid therapeutics;Corey;Nucleic Acid Therapeut.,2022
4. Delivery of RNA therapeutics: the great endosomal escape;Dowdy;Nucleic Acid Therapeut.,2022
5. DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencing;Nishina;Nat. Commun.,2015
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Systemic delivery of a splice-switching oligonucleotide heteroduplex corrects splicing in central nervous system and muscle in spinal muscular atrophy mice;2024-01-25
2. Diabetic Polyneuropathy: New Strategies to Target Sensory Neurons in Dorsal Root Ganglia;International Journal of Molecular Sciences;2023-03-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3